ATYR1923 Specifically Binds to Neuropilin-2, a Novel Therapeutic Target for the Treatment of Immune-Mediated Diseases

Authors :: Roger Adams
L. Zhai
S. Paz
K. Rauch
S. Crampton
L. Burman
S. Rosengren
D. Chu
Z. Xu
L. Nangle
Y. Chong
J. Ampudia
D. King
Source :: B34. ILD CELLULAR MECHANISMS.
Publication Year :: 2020
Publisher :: American Thoracic Society, 2020.

Subjects :: Neuropilin-2
Immune system
business.industry
Cancer research
Medicine
business

Tools